Page 5 - Arix Bioscience News Today

The FTSE 100 closed Wednesday up 0.28%, starting November on a positive note. The month started solidly for European markets with gains across the board as weaker economic data, and a slide in... -November 01, 2023 at 12:59 pm EDT - MarketScreener

The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News: ---------- Gran Tierra Energy Inc -...

London stocks were set for a slightly weaker open on Wednesday following heavy losses on Wall Street.

Biotherapeutics company PureTech Health, which develops medicines to treat serious diseases, has appointed the boss of Arix Bioscience as its new chief portfolio officer.

Arix Bioscience PLC on Wednesday said net asset value increased in its latest half year, but has since launched a strategic review due to unfavourable conditions while Chief Executive Officer Robert...

By Michael Susin Arix Bioscience said Chief Executive Officer Robert Lyne will step down from the company by the end of 2023 to pursue a new opportunity. The...

PureTech Health plc , a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced the appointment of Robert Lyne as Chief...

PureTech Health appoints Robert Lyne as Chief Portfolio Officer

The FTSE 100 closed Wednesday down 0.46%, having fluctuated between positive and negative territory. The worst performers could be found in commercial real estate, while Ocado traded sharply lower...

The chief executive of Arix Bioscience is to step down ahead of a possible winding-down of the former Neil Woodford-backed life sciences investment company.Robe